Buscar resultados de ensayos clínicos
Primary Biliary Cholangitis - 29 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid Condición: Primary Biliary Cholangitis (PBC) Fecha: 2017-03-28 Intervenciones:
|
Recruiting |
Nombre del estudio: Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid Condición: Primary Biliary Cholangitis Fecha: 2017-03-24 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis Condición: Primary Biliary Cholangitis Fecha: 2017-05-11 Intervenciones: Drug: APD334 APD334 active treatment for 24 weeks. O |
Recruiting |
Nombre del estudio: Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis Condición: Primary Biliary Cholangitis Fecha: 2016-06-13 Intervenciones:
|
Recruiting |
Nombre del estudio: MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension) Condición: Primary Biliary Cirrhosis Fecha: 2016-11-02 Intervenciones:
|
Recruiting |
Nombre del estudio: A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of LJN452 in PBC Patients Condición: Primary Biliary Cholangitis Fecha: 2015-08-04 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis Condición: Primary Biliary Cirrhosis Fecha: 2015-12-19 |
Not yet recruiting |
Nombre del estudio: A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS) Condición: Primary Biliary Cirrhosis Fecha: 2017-04-10 Intervenciones:
|
Completed |
Nombre del estudio: Initial Study of Rituximab to Treat Primary Biliary Cirrhosis Condición: Primary Biliary Cirrhosis Fecha: 2006-08-15 Intervenciones: Drug: rituximab rituximab 1000 mg IV day 1 and 15, given over 5 - 6 hours |
Completed |
Nombre del estudio: Moexipril for Primary Biliary Cirrhosis Condición: Primary Biliary Cirrhosis Fecha: 2007-12-22 Intervenciones: Drug: Moexipril Moexipril was given at a starting dose of 7.5 mg daily for 1 week to all enrolled patien |